Home › Carcinoma uroteliale (a cellule transizionali) › Ohio › Columbus
Studi clinici su Carcinoma uroteliale (a cellule transizionali) a Columbus, OH
9 studi su Carcinoma uroteliale (a cellule transizionali) cercano partecipanti presso sedi a Columbus e dintorni (entro circa 30 miglia). Apri uno studio per vedere chi può partecipare e come contattare il team.
Testo ufficiale dello studio (inglese)
Stai reclutando per uno studio? Mettilo in evidenza in cima alla pagina — $99 per 30 giorni →
A Study Comparing the Combination of Pembrolizumab and Sacituzumab Govitecan-hziy Versus Standard of Care in the Treatment of Advanced Urothelial Cancer
In reclutamentoFase 3
- Ohio State University Comprehensive Cancer Center, Columbus
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
In reclutamentoFase 2
- Ohio State University Comprehensive Cancer Center, Columbus
- Mount Carmel East Hospital, Columbus
- Columbus Oncology and Hematology Associates Inc, Columbus
- e altri 11
uTRACT Jelmyto Registry: A Registry of Patients With Upper Tract Urothelial Cancer (UTUC) Treated With Jelmyto
In reclutamentoStudio osservazionale
- Ohio State University, Columbus
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
In reclutamentoFase 3
- The James Cancer Hospital and Solove Research Institute at The Ohio State University Comprehensive Cancer -T, Columbus
A Phase 3 Single-arm Study of UGN-104 for the Treatment of Low-grade Upper Tract Urothelial Cancer
In reclutamentoFase 3
- The James Cancer Hospital and Solove Research Institute, Columbus
A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2
In reclutamentoFase 2
- Ohio State University Hospital, Columbus
- Ohio State University, Columbus
- OSU Wexner Medical Center & James Cancer Hospital, Columbus
- e altri 2
A Study of MT-4561 in Patients With Various Advanced Solid Tumors
In reclutamentoFase 1/2
- The James Cancer Hospital and Solove Research Institute at The Ohio State University Comprehensive Cancer Center, Columbus
Intravesical Photodynamic Therapy ("PDT") in BCG-Unresponsive/Intolerant Non-Muscle Invasive Bladder Cancer ("NMIBC") Patients
In reclutamentoFase 2
- Site 02-017 - Central Ohio Urology Group, Gahanna · a 7 mi di distanza
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
In reclutamentoStudio osservazionale
- Massive Bio SYNERGY-AI site, Columbus
Studi su Carcinoma uroteliale (a cellule transizionali) in altre città
- Nashville, TN23 studi
- New York City, NY22 studi
- Dallas, TX18 studi
- Edison, NJ18 studi
- Houston, TX18 studi
- Los Angeles, CA17 studi
- Queens, NY15 studi
- Chicago, IL14 studi
- Arlington, VA12 studi
- San Antonio, TX11 studi
- Boston, MA11 studi
- Austin, TX10 studi
Altri studi a Columbus
- Cancro del polmone non a piccole cellule56 studi
- Cancro al seno39 studi
- Cancro ovarico39 studi
- Cancro (tutti i tipi)38 studi
- Cancro ai polmoni37 studi
- Leucemia mieloide acuta35 studi
- Leucemia linfatica cronica28 studi
- Cancro metastatico27 studi
- Cancro dell'endometrio25 studi
- Cancro colorettale24 studi
- Cancro alla prostata24 studi
- Mieloma multiplo24 studi
Fonte: ClinicalTrials.gov, dati recuperati il 5 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.